336 related articles for article (PubMed ID: 15098021)
21. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
[TBL] [Abstract][Full Text] [Related]
22. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity.
Tavori H; Khatib S; Aviram M; Vaya J
Bioorg Med Chem; 2008 Aug; 16(15):7504-9. PubMed ID: 18572410
[TBL] [Abstract][Full Text] [Related]
24. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates.
Yeung DT; Lenz DE; Cerasoli DM
FEBS J; 2005 May; 272(9):2225-30. PubMed ID: 15853807
[TBL] [Abstract][Full Text] [Related]
25. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.
Tavori H; Vaya J; Aviram M
Adv Exp Med Biol; 2010; 660():99-111. PubMed ID: 20221874
[TBL] [Abstract][Full Text] [Related]
27. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
Connelly PW; Draganov D; Maguire GF
Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
[TBL] [Abstract][Full Text] [Related]
28. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
[TBL] [Abstract][Full Text] [Related]
29. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
Rozenberg O; Aviram M
Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
[TBL] [Abstract][Full Text] [Related]
30. The structure of a bacterial L-amino acid oxidase from Rhodococcus opacus gives new evidence for the hydride mechanism for dehydrogenation.
Faust A; Niefind K; Hummel W; Schomburg D
J Mol Biol; 2007 Mar; 367(1):234-48. PubMed ID: 17234209
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon bovines.
Erzengin M; Demir D; Arslan M; Sinan S
Appl Biochem Biotechnol; 2014 Aug; 173(7):1597-606. PubMed ID: 24907040
[TBL] [Abstract][Full Text] [Related]
32. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of organophosphorus hydrolase variants with high degradation activity towards organophosphate pesticides.
Mee-Hie Cho C; Mulchandani A; Chen W
Protein Eng Des Sel; 2006 Mar; 19(3):99-105. PubMed ID: 16423845
[TBL] [Abstract][Full Text] [Related]
34. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
[TBL] [Abstract][Full Text] [Related]
35. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.
Yeung DT; Josse D; Nicholson JD; Khanal A; McAndrew CW; Bahnson BJ; Lenz DE; Cerasoli DM
Biochim Biophys Acta; 2004 Oct; 1702(1):67-77. PubMed ID: 15450851
[TBL] [Abstract][Full Text] [Related]
36. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
37. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
Deakin SP; James RW
Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of glycoside hydrolase family 78 alpha-L-Rhamnosidase from Bacillus sp. GL1.
Cui Z; Maruyama Y; Mikami B; Hashimoto W; Murata K
J Mol Biol; 2007 Nov; 374(2):384-98. PubMed ID: 17936784
[TBL] [Abstract][Full Text] [Related]
39. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism.
Ishizuka T; Fujimori I; Nishida A; Sakurai H; Yoshigae Y; Nakahara K; Kurihara A; Ikeda T; Izumi T
Drug Metab Dispos; 2012 Feb; 40(2):374-80. PubMed ID: 22086979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
